Effects of Dietary Phytochemicals on DNA Damage in Cancer Cells

References

• Ma L, Zhang M, Zhao R, Wang D, Ma Y, Ai L. Plant natural products: promising resources for cancer chemoprevention. Molecules. 2021;26(4):933.
   PubMed Web of Science ®Google Scholar
• Chen JT. Phytochemical omics in medicinal plants. Biomolecules. 2020;10(6):936.
   PubMed Web of Science ®Google Scholar
• Lee J, Han Y, Wang W, Jo H, Kim H, Kim S, Yang K-M, Kim S-J, Dhanasekaran DN, Song YS, et al. Phytochemicals in cancer immune checkpoint inhibitor therapy. Biomolecules. 2021;11(8):1107.
   PubMed Web of Science ®Google Scholar
• Ranjan A, et al. Role of phytochemicals in cancer prevention. Int J Mol Sci. 2019;20(20).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu X, Ruan J, Zhuang X, Zhang X, Li Z. Phytochemicals of garlic: promising candidates for cancer therapy. Biomed Pharmacother. 2020;123:109730.
   PubMed Web of Science ®Google Scholar
• Baby B, Antony P, Vijayan R. Antioxidant and anticancer properties of berries. Crit Rev Food Sci Nutr. 2018;58(15):2491–507.
   PubMed Web of Science ®Google Scholar
• Chien C-M, Yang J-C, Wu P-H, Wu C-Y, Chen G-Y, Wu Y-C, Chou C-K, Tseng C-H, Chen Y-L, Wang L-F, et al. Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer. Phytomedicine. 2019;54:109–19.
   PubMed Web of Science ®Google Scholar
• Pilié PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16(2):81–104.
   PubMed Web of Science ®Google Scholar
• Bacanlı M, Aydın S, Başaran AA, Başaran N. Are all phytochemicals useful in the preventing of DNA damage? Food Chem Toxicol. 2017;109(Pt 1):210–7.
   PubMed Web of Science ®Google Scholar
• Nichols JA, Katiyar SK. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res. 2010;302(2):71–83.
   PubMed Web of Science ®Google Scholar
• Lu L, Jiang M, Zhu C, He J, Fan S. Amelioration of whole abdominal irradiation-induced intestinal injury in mice with 3,3’-diindolylmethane (DIM). Free Radic Biol Med. 2019;130:244–55.
   PubMed Web of Science ®Google Scholar
• Bonnesen C, Eggleston IM, Hayes JD. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res. 2001;61(16):6120–30.
   PubMed Web of Science ®Google Scholar
• Li H, Gao A, Jiang N, Liu Q, Liang B, Li R, Zhang E, Li Z, Zhu H. Protective effect of curcumin against acute ultraviolet B irradiation-induced photo-damage. Photochem Photobiol. 2016;92(6):808–15.
   PubMed Web of Science ®Google Scholar
• Farhan M, Rizvi A, Ahmad A, Aatif M, Alam MW, Hadi SM. Structure of some green tea catechins and the availability of intracellular copper influence their ability to cause selective oxidative DNA damage in malignant cells. Biomedicines. 2022;10(3):664.
   PubMed Web of Science ®Google Scholar
• Wu W, Dong J, Gou H, Geng R, Yang X, Chen D, Xiang B, Zhang Z, Ren S, Chen L, et al. EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells. J Cell Mol Med. 2021;25(16):7913–21.
   PubMed Web of Science ®Google Scholar
• La X, Zhang L, Li Z, Li H, Yang Y. (-)-Epigallocatechin gallate (EGCG) enhances the sensitivity of colorectal cancer cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 pathway. J Agric Food Chem. 2019;67(9):2510–8.
   PubMed Web of Science ®Google Scholar
• Udroiu I, Marinaccio J, Sgura A. Epigallocatechin-3-gallate induces telomere shortening and clastogenic damage in glioblastoma cells. Environ Mol Mutagen. 2019;60(8):683–92.
   PubMed Web of Science ®Google Scholar
• Rao SD, Pagidas K. Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Anticancer Res. 2010;30(7):2519–23.
   PubMed Web of Science ®Google Scholar
• Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis. 2014;35(8):1872–80.
   PubMed Web of Science ®Google Scholar
• Sui X, Zhang C, Zhou J, Cao S, Xu C, Tang F, Zhi X, Chen B, Wang S, Yin L, et al. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway. J Exp Clin Cancer Res. 2017;36(1):133.
   PubMed Web of Science ®Google Scholar
• Fu X, Li M, Tang C, Huang Z, Najafi M. Targeting of cancer cell death mechanisms by resveratrol: a review. Apoptosis. 2021;26(11-12):561–73.
   PubMed Web of Science ®Google Scholar
• Demoulin B, Hermant M, Castrogiovanni C, Staudt C, Dumont P. Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase II and activates the ATM kinase to trigger p53-dependent apoptosis. Toxicol in Vitro. 2015;29(5):1156–65.
   PubMed Web of Science ®Google Scholar
• Yeh Y-T, Hsu Y-N, Huang S-Y, Lin J-S, Chen Z-F, Chow N-H, Su S-H, Shyu H-W, Lin C-C, Huang W-T, et al. Benzyl isothiocyanate promotes apoptosis of oral cancer cells via an acute redox stress-mediated DNA damage response. Food Chem Toxicol. 2016;97:336–45.
   PubMed Web of Science ®Google Scholar
• Zhang R, Loganathan S, Humphreys I, Srivastava SK. Benzyl isothiocyanate-induced DNA damage causes G2/M cell cycle arrest and apoptosis in human pancreatic cancer cells. J Nutr. 2006;136(11):2728–34.
   PubMed Web of Science ®Google Scholar
• Huang Y-P, Jiang Y-W, Chen H-Y, Hsiao Y-T, Peng S-F, Chou Y-C, Yang J-L, Hsia T-C, Chung J-G. Benzyl isothiocyanate induces apoptotic cell death through mitochondria-dependent pathway in gefitinib-resistant NCI-H460 human lung cancer cells in vitro. Anticancer Res. 2018;38(9):5165–76.
   PubMed Web of Science ®Google Scholar
• Günes-Bayir A, Kiziltan HS, Kocyigit A, Güler EM, Karataş E, Toprak A. Effects of natural phenolic compound carvacrol on the human gastric adenocarcinoma (AGS) cells in vitro. Anticancer Drugs. 2017;28(5):522–30.
   PubMed Web of Science ®Google Scholar
• Ozkan A, Erdogan A. A comparative study of the antioxidant/prooxidant effects of carvacrol and thymol at various concentrations on membrane and DNA of parental and drug resistant H1299 cells. Nat Prod Commun. 2012;7(12):1557–60.
   PubMed Web of Science ®Google Scholar
• Guha Majumdar A, Subramanian M. Hydroxychavicol from piper betle induces apoptosis, cell cycle arrest, and inhibits epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Pharmacol. 2019;166:274–91.
   PubMed Web of Science ®Google Scholar
• Gundala SR, Yang C, Mukkavilli R, Paranjpe R, Brahmbhatt M, Pannu V, Cheng A, Reid MD, Aneja R. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis. Toxicol Appl Pharmacol. 2014;280(1):86–96.
   PubMed Web of Science ®Google Scholar
• Dos Santos PWdS, Machado ART, De Grandis RA, Ribeiro DL, Tuttis K, Morselli M, Aissa AF, Pellegrini M, Antunes LMG. Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020;136:111047.
   PubMed Web of Science ®Google Scholar
• Naumann P, Liermann J, Fortunato F, Schmid TE, Weber K-J, Debus J, Combs SE. Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells. PLoS One. 2017;12(7):e0180940.
   PubMed Web of Science ®Google Scholar
• Russo M, Spagnuolo C, Russo GL, Skalicka-Woźniak K, Daglia M, Sobarzo-Sánchez E, Nabavi SF, Nabavi SM. Nrf2 targeting by sulforaphane: a potential therapy for cancer treatment. Crit Rev Food Sci Nutr. 2018;58(8):1391–405.
   PubMed Web of Science ®Google Scholar
• Tong R, Wu X, Liu Y, Liu Y, Zhou J, Jiang X, Zhang L, He X, Ma L. Curcumin-induced DNA demethylation in human gastric cancer cells is mediated by the DNA-damage response pathway. Oxid Med Cell Longev. 2020;2020:2543504.
   PubMed Web of Science ®Google Scholar
• Guney Eskiler G, Sahin E, Deveci Ozkan A, Cilingir Kaya OT, Kaleli S. Curcumin induces DNA damage by mediating homologous recombination mechanism in triple negative breast cancer. Nutr Cancer. 2020;72(6):1057–66.
   PubMed Web of Science ®Google Scholar
• Li K, Zhao S, Long J, Su J, Wu L, Tao J, Zhou J, Zhang J, Chen X, Peng C, et al. A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products. Cancer Cell Int. 2020;20:36.
   PubMed Web of Science ®Google Scholar
• Gil HN, Jung E, Koh D, Lim Y, Lee YH, Shin SY. A synthetic chalcone derivative, 2-hydroxy-3’,5,5’-trimethoxychalcone (DK-139), triggers reactive oxygen species-induced apoptosis independently of p53 in A549 lung cancer cells. Chem Biol Interact. 2019;298:72–9.
   PubMed Web of Science ®Google Scholar
• WalyEldeen AA, El-Shorbagy HM, Hassaneen HM, Abdelhamid IA, Sabet S, Ibrahim SA. [1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice. Naunyn-Schmiedeberg’s Arch Pharmacol. 2022;395(10):1225–38.
   Google Scholar
• Utama K, Khamto N, Meepowpan P, Aobchey P, Kantapan J, Sringarm K, Roytrakul S, Sangthong P. Effects of 2’,4’-dihydroxy-6’-methoxy-3’,5’-dimethylchalcone from Syzygium nervosum seeds on antiproliferative, DNA damage, cell cycle arrest, and apoptosis in human cervical cancer cell lines. Molecules. 2022;27(4):1154.
   PubMed Web of Science ®Google Scholar
• Sameni S, Hande MP. Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells. Biomed Pharmacother. 2016;82:256–68.
   PubMed Web of Science ®Google Scholar
• Panda M, Tripathi SK, Biswal BK. Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation. Mol Biol Rep. 2020;47(6):4155–68.
   PubMed Web of Science ®Google Scholar
• Pandey K, Tripathi SK, Panda M, Biswal BK. Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway. Toxicol in Vitro. 2020;65:104788.
   PubMed Web of Science ®Google Scholar
• Park H, et al. Oridonin enhances radiation-induced cell death by promoting DNA damage in non-small cell lung cancer cells. Int J Mol Sci. 2018;19(8):2378.
   PubMed Web of Science ®Google Scholar
• Yang I-H, Shin J-A, Lee K-E, Kim J, Cho N-P, Cho S-D. Oridonin induces apoptosis in human oral cancer cells via phosphorylation of histone H2AX. Eur J Oral Sci. 2017;125(6):438–43.
   PubMed Web of Science ®Google Scholar
• Xu B, Shen W, Liu X, Zhang T, Ren J, Fan Y, Xu J. Oridonin inhibits BxPC-3 cell growth through cell apoptosis. Acta Biochim Biophys Sin (Shanghai). 2015;47(3):164–73.
   PubMed Web of Science ®Google Scholar
• Palomera-Sanchez Z, Watson GW, Wong CP, Beaver LM, Williams DE, Dashwood RH, Ho E. The phytochemical 3,3’-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells. J Nutr Biochem. 2017;47:113–9.
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Guo B. Chemopreventive agent 3,3’-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases. Cancer Res. 2010;70(2):646–54.
   PubMed Web of Science ®Google Scholar
• Kandala PK, Srivastava SK. Activation of checkpoint kinase 2 by 3,3’-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells. Mol Pharmacol. 2010;78(2):297–309.
   PubMed Web of Science ®Google Scholar
• Shendge AK, Chaudhuri D, Basu T, Mandal N. A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway. Clin Transl Oncol. 2021;23(4):718–30.
   PubMed Web of Science ®Google Scholar
• Lee Y-J, Park K-S, Nam H-S, Cho M-K, Lee S-H. Apigenin causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells. Korean J Physiol Pharmacol. 2020;24(6):493–502.
   PubMed Web of Science ®Google Scholar
• Jia C, Zhao Y, Huang H, Fan K, Xie T, Xie M. Apigenin sensitizes radiotherapy of mouse subcutaneous glioma through attenuations of cell stemness and DNA damage repair by inhibiting NF-κB/HIF-1α-mediated glycolysis. J Nutr Biochem. 2022;107:109038.
   PubMed Web of Science ®Google Scholar
• Liu W-J, Yin Y-B, Sun J-Y, Feng S, Ma J-K, Fu X-Y, Hou Y-J, Yang M-F, Sun B-L, Fan C-D, et al. Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage. Onco Targets Ther. 2018;11:5429–39.
   PubMed Web of Science ®Google Scholar
• Chen J, Li L, Su J, Chen T. Natural borneol enhances bisdemethoxycurcumin-induced cell cycle arrest in the G2/M phase through up-regulation of intracellular ROS in HepG2 cells. Food Funct. 2015;6(3):740–8.
   PubMed Web of Science ®Google Scholar
• Guo J, Wu G, Bao J, Hao W, Lu J, Chen X. Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner. PLoS One. 2014;9(2):e88140.
   PubMed Web of Science ®Google Scholar
• Niu Y, Sun W, Lu J-J, Ma D-L, Leung C-H, Pei L, Chen X. PTEN activation by DNA damage induces protective autophagy in response to cucurbitacin B in hepatocellular carcinoma cells. Oxid Med Cell Longev. 2016;2016:4313204.
   PubMed Web of Science ®Google Scholar
• Ren G, Sha T, Guo J, Li W, Lu J, Chen X. Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells. J Nat Med. 2015;69(4):522–30.
   PubMed Web of Science ®Google Scholar
• Chueh F-S, Chen Y-L, Hsu S-C, Yang J-S, Hsueh S-C, Ji B-C, Lu H-F, Chung J-G. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Oncol Rep. 2013;29(2):613–8.
   PubMed Web of Science ®Google Scholar
• Qiao Z, He M, He MU, Li W, Wang X, Wang Y, Kuai Q, Li C, Ren S, Yu Q, et al. Synergistic antitumor activity of gemcitabine combined with triptolide in pancreatic cancer cells. Oncol Lett. 2016;11(5):3527–33.
   PubMed Web of Science ®Google Scholar
• Tang J-Y, Huang H-W, Wang H-R, Chan Y-C, Haung J-W, Shu C-W, Wu Y-C, Chang H-W. 4β-Hydroxywithanolide E selectively induces oxidative DNA damage for selective killing of oral cancer cells. Environ Toxicol. 2018;33(3):295–304.
   PubMed Web of Science ®Google Scholar
• You B-J, Wu Y-C, Lee C-L, Lee H-Z. Non-homologous end joining pathway is the major route of protection against 4β-hydroxywithanolide E-induced DNA damage in MCF-7 cells. Food Chem Toxicol. 2014;65:205–12.
   PubMed Web of Science ®Google Scholar
• Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12(12):801–17.
   PubMed Web of Science ®Google Scholar
• Lindahl T. Instability and decay of the primary structure of DNA. Nature. 1993;362(6422):709–15.
   PubMed Web of Science ®Google Scholar
• Carusillo A, Mussolino C. DNA damage: from threat to treatment. Cells. 2020;9(7):1665.
   PubMed Web of Science ®Google Scholar
• Ui A, Chiba N, Yasui A. Relationship among DNA double-strand break (DSB), DSB repair, and transcription prevents genome instability and cancer. Cancer Sci. 2020;111(5):1443–51.
   PubMed Web of Science ®Google Scholar
• Ma A, Dai X. The relationship between DNA single-stranded damage response and double-stranded damage response. Cell Cycle. 2018;17(1):73–9.
   PubMed Web of Science ®Google Scholar
• Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40(2):179–204.
   PubMed Web of Science ®Google Scholar
• Santivasi WL, Xia F. Ionizing radiation-induced DNA damage, response, and repair. Antioxid Redox Signal. 2014;21(2):251–9.
   PubMed Web of Science ®Google Scholar
• Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 2020;30(6):440–51.
   PubMed Web of Science ®Google Scholar
• Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T, Chen D, Piao H-L, Liu H-X. The double-edged roles of ROS in cancer prevention and therapy. Theranostics. 2021;11(10):4839–57.
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Tuli H, Varol A, Thakral F, Yerer M, Sak K, Varol M, Jain A, Khan M, Sethi G, et al. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 2019;9(11):735.
   PubMed Web of Science ®Google Scholar
• Rahmanian N, Shokrzadeh M, Eskandani M. Recent advances in γH2AX biomarker-based genotoxicity assays: a marker of DNA damage and repair. DNA Repair (Amst). 2021;108:103243.
   PubMed Web of Science ®Google Scholar
• Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol. 1999;146(5):905–16.
   PubMed Web of Science ®Google Scholar
• Bartkova J, Horejsí Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434(7035):864–70.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang D, Ramos KS, Baks L, Wiersma M, Lanters EAH, Bogers AJJC, de Groot NMS, Brundel BJJM. Blood-based 8-hydroxy-2’-deoxyguanosine level: a potential diagnostic biomarker for atrial fibrillation. Heart Rhythm. 2021;18(2):271–7.
   PubMed Web of Science ®Google Scholar
• Urbaniak SK, Boguszewska K, Szewczuk M, Kaźmierczak-Barańska J, Karwowski BT. 8-Oxo-7,8-dihydro-2’-deoxyguanosine (8-oxodG) and 8-hydroxy-2’-deoxyguanosine (8-OHdG) as a potential biomarker for gestational diabetes mellitus (GDM) development. Molecules. 2020;25(1):202.
   PubMed Web of Science ®Google Scholar
• Mazlumoglu MR, Ozkan O, Alp HH, Ozyildirim E, Bingol F, Yoruk O, Kuduban O. Measuring oxidative DNA damage with 8-hydroxy-2’-deoxyguanosine levels in patients with laryngeal cancer. Ann Otol Rhinol Laryngol. 2017;126(2):103–9.
   PubMed Web of Science ®Google Scholar
• Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, et al. Characterization of human Gadd45, a p53-regulated protein. J Biol Chem. 1994;269(51):32672–7.
   PubMed Web of Science ®Google Scholar
• Reddy SP, Britto R, Vinnakota K, Aparna H, Sreepathi HK, Thota B, Kumari A, Shilpa BM, Vrinda M, Umesh S, et al. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Clin Cancer Res. 2008;14(10):2978–87.
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang G, Mao P, Zhang J, Zhang L, Liu L, Wang J, Owusu L, Ren B, Tang Y, et al. Down-regulation of GADD45A enhances chemosensitivity in melanoma. Sci Rep. 2018;8(1):4111.
   PubMed Web of Science ®Google Scholar
• Ehmsen JT, Kawaguchi R, Kaval D, Johnson AE, Nachun D, Coppola G, Höke A. GADD45A is a protective modifier of neurogenic skeletal muscle atrophy. JCI Insight. 2021;6(13):e149381.
   PubMed Web of Science ®Google Scholar
• Tront JS, Willis A, Huang Y, Hoffman B, Liebermann DA. Gadd45a levels in human breast cancer are hormone receptor dependent. J Transl Med. 2013;11:131.
   PubMed Web of Science ®Google Scholar
• Su M-Q, Zhou Y-R, Rao X, Yang H, Zhuang X-H, Ke X-J, Peng G-Y, Zhou C-L, Shen B-Y, Dou J, et al. Baicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/Gadd45a and activation of MAPKs. Int J Oncol. 2018;53(2):750–60.
   PubMed Web of Science ®Google Scholar
• Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, Mazzacurati L, Li X, Petrik KL, Rajasekaran B, et al. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene. 2002;21(57):8696–704.
   PubMed Web of Science ®Google Scholar
• Asuthkar S, Nalla AK, Gondi CS, Dinh DH, Gujrati M, Mohanam S, Rao JS. Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT. Neuro Oncol. 2011;13(10):1059–73.
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang W, Li D, Zhan Q. Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway. J Biol Chem. 2013;288(9):6552–60.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang R-H, Li W, Xu X, Hollander MC, Fornace AJ, Deng C-X. Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure. J Biol Chem. 2004;279(28):29606–14.
   PubMed Web of Science ®Google Scholar
• Dutt R, Garg V, Khatri N, Madan AK. Phytochemicals in Anticancer Drug Development. ACAMC. 2019;19(2):172–83.
   Web of Science ®Google Scholar
• Ye Y, Li X, Wang Z, Ye F, Xu W, Lu R, Shen H, Miao S. 3,3’-Diindolylmethane induces gastric cancer cells death via STIM1 mediated store-operated calcium entry. Int J Biol Sci. 2021;17(5):1217–33.
   PubMed Web of Science ®Google Scholar
• Chen CY, Kao CL, Liu CM. The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway. Int J Mol Sci. 2018;19(9):2729.
   PubMed Web of Science ®Google Scholar
• Rashidi B, Malekzadeh M, Goodarzi M, Masoudifar A, Mirzaei H. Green tea and its anti-angiogenesis effects. Biomed Pharmacother. 2017;89:949–56.
   PubMed Web of Science ®Google Scholar
• Chikara S, Nagaprashantha LD, Singhal J, Horne D, Awasthi S, Singhal SS. Oxidative stress and dietary phytochemicals: role in cancer chemoprevention and treatment. Cancer Lett. 2018;413:122–34.
   PubMed Web of Science ®Google Scholar
• Khan N, Mukhtar H. Tea polyphenols in promotion of human health. Nutrients. 2018;11(1):39.
   PubMed Web of Science ®Google Scholar
• Chen K, et al. Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway. Mol Med Rep. 2018;17(6):7652–60.
   PubMed Web of Science ®Google Scholar
• Ng CY, et al. Phytochemicals in skin cancer prevention and treatment: an updated review. Int J Mol Sci. 2018;19(4):941.
   PubMed Web of Science ®Google Scholar
• Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem. 2011;53:155–77.
   PubMed Web of Science ®Google Scholar
• Oya Y, Mondal A, Rawangkan A, Umsumarng S, Iida K, Watanabe T, Kanno M, Suzuki K, Li Z, Kagechika H, et al. Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin. J Nutr Biochem. 2017;42:7–16.
   PubMed Web of Science ®Google Scholar
• Galiniak S, Aebisher D, Bartusik-Aebisher D. Health benefits of resveratrol administration. Acta Biochim Pol. 2019;66(1):13–21.
   PubMed Web of Science ®Google Scholar
• Breuss JM, Atanasov AG, Uhrin P. Resveratrol and its effects on the vascular system. Int J Mol Sci. 2019;20(7):1523.
   PubMed Web of Science ®Google Scholar
• Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J. Anti-inflammatory action and mechanisms of resveratrol. Molecules. 2021;26(1):229.
   PubMed Web of Science ®Google Scholar
• Vervandier-Fasseur D, Latruffe N. The potential use of resveratrol for cancer prevention. Molecules. 2019;24(24):4506.
   PubMed Web of Science ®Google Scholar
• Tyagi A, Gu M, Takahata T, Frederick B, Agarwal C, Siriwardana S, Agarwal R, Sclafani RA. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clin Cancer Res. 2011;17(16):5402–11.
   PubMed Web of Science ®Google Scholar
• Singh V, Singh R, Kujur PK, Singh RP. Combination of resveratrol and quercetin causes cell growth inhibition, DNA damage, cell cycle arrest, and apoptosis in oral cancer cells. Assay Drug Dev Technol. 2020;18(5):226–38.
   PubMed Web of Science ®Google Scholar
• Dinh TN, Parat M-O, Ong YS, Khaw KY. Anticancer activities of dietary benzyl isothiocyanate: a comprehensive review. Pharmacol Res. 2021;169:105666.
   PubMed Web of Science ®Google Scholar
• Tang N-Y, Chueh F-S, Yu C-C, Liao C-L, Lin J-J, Hsia T-C, Wu K-C, Liu H-C, Lu K-W, Chung J-G, et al. Benzyl isothiocyanate alters the gene expression with cell cycle regulation and cell death in human brain glioblastoma GBM 8401 cells. Oncol Rep. 2016;35(4):2089–96.
   PubMed Web of Science ®Google Scholar
• Silva ER, de Carvalho FO, Teixeira LGB, Santos NGL, Felipe FA, Santana HSR, Shanmugam S, Quintans Júnior LJ, de Souza Araújo AA, Nunes PS, et al. Pharmacological effects of carvacrol in in vitro studies: a review. Curr Pharm Des. 2018;24(29):3454–65.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Saeed M, Ansari IA. Molecular insights on chemopreventive and anticancer potential of carvacrol: implications from solid carcinomas. J Food Biochem. 2021;45(12):e14010.
   PubMed Web of Science ®Google Scholar
• Ferguson LR. Role of plant polyphenols in genomic stability. Mutat Res. 2001;475(1-2):89–111.
   PubMed Web of Science ®Google Scholar
• Sekar VD, Ramasamy GD, Ravikumar C. In silico molecular docking for assessing anti-fungal competency of hydroxychavicol, a phenolic compound of betel leaf (Piper betle L.) against COVID-19 associated maiming mycotic infections. Drug Dev Ind Pharm. 2022;48(5):1–43.
   PubMed Web of Science ®Google Scholar
• Rajedadram A, Pin KY, Ling SK, Yan SW, Looi ML. Hydroxychavicol, a polyphenol from Piper betle leaf extract, induces cell cycle arrest and apoptosis in TP53-resistant HT-29 colon cancer cells. J Zhejiang Univ Sci B. 2021;22(2):112–22.
   PubMed Web of Science ®Google Scholar
• Li J, Xie S, Teng W. Sulforaphane attenuates nonalcoholic fatty liver disease by inhibiting hepatic steatosis and apoptosis. Nutrients. 2021;14(1):76.
   PubMed Web of Science ®Google Scholar
• Cardozo LFMF, Alvarenga LA, Ribeiro M, Dai L, Shiels PG, Stenvinkel P, Lindholm B, Mafra D. Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease. Nutr Rev. 2021;79(11):1204–24.
   PubMed Web of Science ®Google Scholar
• Schepici G, Bramanti P, Mazzon E. Efficacy of sulforaphane in neurodegenerative diseases. Int J Mol Sci. 2020;21(22):8637.
   PubMed Web of Science ®Google Scholar
• Zheng K, Ma J, Wang Y, He Z, Deng K. Sulforaphane inhibits autophagy and induces exosome-mediated paracrine senescence via regulating mTOR/TFE3. Mol Nutr Food Res. 2020;64(14):e1901231.
   PubMed Web of Science ®Google Scholar
• Peixoto P, Castronovo V, Matheus N, Polese C, Peulen O, Gonzalez A, Boxus M, Verdin E, Thiry M, Dequiedt F, et al. HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death Differ. 2012;19(7):1239–52.
   PubMed Web of Science ®Google Scholar
• Rudolf E, Cervinka M. Sulforaphane induces cytotoxicity and lysosome- and mitochondria-dependent cell death in colon cancer cells with deleted p53. Toxicol in Vitro. 2011;25(7):1302–9.
   PubMed Web of Science ®Google Scholar
• Ferreira de Oliveira JMP, Remédios C, Oliveira H, Pinto P, Pinho F, Pinho S, Costa M, Santos C. Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis. Nutr Cancer. 2014;66(2):325–34.
   PubMed Web of Science ®Google Scholar
• Topè AM, Rogers PF. Evaluation of protective effects of sulforaphane on DNA damage caused by exposure to low levels of pesticide mixture using comet assay. J Environ Sci Health B. 2009;44(7):657–62.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. Aaps J. 2013;15(1):195–218.
   PubMed Web of Science ®Google Scholar
• Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014:186864.
   PubMed Web of Science ®Google Scholar
• Liczbiński P, Michałowicz J, Bukowska B. Molecular mechanism of curcumin action in signaling pathways: review of the latest research. Phytother Res. 2020;34(8):1992–2005.
   PubMed Web of Science ®Google Scholar
• Momtazi AA, et al. Curcumin as a microRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol. 2016;171:1–38.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Guan J, Qin Y, Ren P, Zhang Z, Lv J, Sun S, Zhang C, Mao W. Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination. Biomed Pharmacother. 2018;97:115–9.
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Li J, Chen X, Fu X, Sun S, Wu Q. Chalcone derivatives: role in anticancer therapy. Biomolecules. 2021;11(6):894.
   PubMed Web of Science ®Google Scholar
• Helmy MT, Sroor FM, Mahrous KF, Mahmoud K, Hassaneen HM, Saleh FM, Abdelhamid IA, Mohamed Teleb MA. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: synthesis and in vitro studies. Arch Pharm (Weinheim). 2022;355(3):e2100381.
   PubMed Web of Science ®Google Scholar
• Tripathi SK, Panda M, Biswal BK. Emerging role of plumbagin: cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food Chem Toxicol. 2019;125:566–82.
   PubMed Web of Science ®Google Scholar
• Yuan J-H, Pan F, Chen J, Chen C-E, Xie D-P, Jiang X-Z, Guo S-J, Zhou J. Neuroprotection by plumbagin involves BDNF-TrkB-PI3K/Akt and ERK1/2/JNK pathways in isoflurane-induced neonatal rats. J Pharm Pharmacol. 2017;69(7):896–906.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang C-T, Ma W, Xie X, Huang Q. Oridonin: a review of its pharmacology, pharmacokinetics and toxicity. Front Pharmacol. 2021;12:645824.
   PubMed Web of Science ®Google Scholar
• Xu Z-Z, Fu W-B, Jin Z, Guo P, Wang W-F, Li J-M. Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma. Leuk Lymphoma. 2016;57(4):888–98.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhong Z, Wan J, Tan W, Wu G, Chen M, Wang Y. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. Am J Chin Med. 2013;41(1):177–96.
   PubMed Web of Science ®Google Scholar
• Ge X, Yannai S, Rennert G, Gruener N, Fares FA. 3,3’-Diindolylmethane induces apoptosis in human cancer cells. Biochem Biophys Res Commun. 1996;228(1):153–8.
   PubMed Web of Science ®Google Scholar
• Salehi B, et al. The therapeutic potential of apigenin. Int J Mol Sci. 2019;20(6):1305.
   PubMed Web of Science ®Google Scholar
• Imran M, Aslam Gondal T, Atif M, Shahbaz M, Batool Qaisarani T, Hanif Mughal M, Salehi B, Martorell M, Sharifi-Rad J. Apigenin as an anticancer agent. Phytother Res. 2020;34(8):1812–28.
   PubMed Web of Science ®Google Scholar
• Vrhovac Madunić I, Madunić J, Antunović M, Paradžik M, Garaj-Vrhovac V, Breljak D, Marijanović I, Gajski G. Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(5):537–50.
   PubMed Web of Science ®Google Scholar
• Masuelli L, Benvenuto M, Mattera R, Di Stefano E, Zago E, Taffera G, Tresoldi I, Giganti MG, Frajese GV, Berardi G, et al. In vitro and in vivo anti-tumoral effects of the flavonoid apigenin in malignant mesothelioma. Front Pharmacol. 2017;8:373.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cheng X, Gao Y, Zheng J, Xu Q, Sun Y, Guan H, Yu H, Sun Z. Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food Funct. 2015;6(11):3464–72.
   PubMed Web of Science ®Google Scholar
• Cao W-Q, Zhai X-Q, Ma J-W, Fu X-Q, Zhao B-S, Zhang P, Fu X-Y. Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway. Pharm Biol. 2020;58(1):72–9.
   PubMed Web of Science ®Google Scholar
• Cao W-Q, Li Y, Hou Y-J, Yang M-X, Fu X-Q, Zhao B-S, Jiang H-M, Fu X-Y. Enhanced anticancer efficiency of doxorubicin against human glioma by natural borneol through triggering ROS-mediated signal. Biomed Pharmacother. 2019;118:109261.
   PubMed Web of Science ®Google Scholar
• Luo H, Vong CT, Chen H, Gao Y, Lyu P, Qiu L, Zhao M, Liu Q, Cheng Z, Zou J, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48.
   PubMed Web of Science ®Google Scholar
• Ma W, Xiang Y, Yang R, Zhang T, Xu J, Wu Y, Liu X, Xiang K, Zhao H, Liu Y, et al. Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia. J Pharmacol Sci. 2019;139(4):304–10.
   PubMed Web of Science ®Google Scholar
• Touihri-Barakati I, Kallech-Ziri O, Ayadi W, Kovacic H, Hanchi B, Hosni K, Luis J. Cucurbitacin B purified from Ecballium elaterium (L.) A. Rich from Tunisia inhibits α5β1 integrin-mediated adhesion, migration, proliferation of human glioblastoma cell line and angiogenesis. Eur J Pharmacol. 2017;797:153–61.
   PubMed Web of Science ®Google Scholar
• Yuan R, Zhao W, Wang Q-Q, He J, Han S, Gao H, Feng Y, Yang S. Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis. Pharmacol Res. 2021;170:105748.
   PubMed Web of Science ®Google Scholar
• Lin Y, Kotakeyama Y, Li J, Pan Y, Matsuura A, Ohya Y, Yoshida M, Xiang L, Qi J. Cucurbitacin B exerts antiaging effects in yeast by regulating autophagy and oxidative stress. Oxid Med Cell Longev. 2019;2019:1–15.
   Web of Science ®Google Scholar
• Noel P, Von Hoff DD, Saluja AK, Velagapudi M, Borazanci E, Han H. Triptolide and its derivatives as cancer therapies. Trends Pharmacol Sci. 2019;40(5):327–41.
   PubMed Web of Science ®Google Scholar
• Xi C, Peng S, Wu Z, Zhou Q, Zhou J. Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother. 2017;90:531–41.
   PubMed Web of Science ®Google Scholar
• Zhao F, Huang W, Ousman T, Zhang B, Han Y, Clotaire DZJ, Wang C, Chang H, Luo H, Ren X, et al. Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation. PLoS One. 2013;8(11):e80784.
   PubMed Web of Science ®Google Scholar
• Deng Y, Li F, He P, Yang Y, Yang J, Zhang Y, Liu J, Tong Y, Li Q, Mei X, et al. Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition. Mol Carcinog. 2018;57(6):807–14.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Sun C, Zhang L, Chi X, Ji J, Gao X, Wang Y, Zhao Z, Liu L, Cao X, et al. Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin. Biomed Pharmacother. 2019;109:1541–6.
   PubMed Web of Science ®Google Scholar
• Takimoto T, Kanbayashi Y, Toyoda T, Adachi Y, Furuta C, Suzuki K, Miwa T, Bannai M. 4β-Hydroxywithanolide E isolated from Physalis pruinosa calyx decreases ­inflammatory responses by inhibiting the NF-κB ­signaling in diabetic mouse adipose tissue. Int J Obes (Lond). 2014;38(11):1432–9.
   PubMed Web of Science ®Google Scholar
• Hsieh K-Y, Tsai J-Y, Lin Y-H, Chang F-R, Wang H-C, Wu C-C. Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells. Sci Rep. 2021;11(1):4610.
   PubMed Web of Science ®Google Scholar
• Ye Z-N, Yuan F, Liu J-Q, Peng X-R, An T, Li X, Kong L-M, Qiu M-H, Li Y. Physalis peruviana-derived 4β-hydroxywithanolide E, a novel antagonist of Wnt signaling, inhibits colorectal cancer in vitro and in vivo. Molecules. 2019;24(6):1146.
   PubMed Web of Science ®Google Scholar
• Yang W-J, Chen X-M, Wang S-Q, Hu H-X, Cheng X-P, Xu L-T, Ren D-M, Wang X-N, Zhao B-B, Lou H-X, et al. 4β-hydroxywithanolide E from Goldenberry (whole fruits of Physalis peruviana L.) as a promising agent against chronic obstructive pulmonary disease. J Nat Prod. 2020;83(4):1217–28.
   PubMed Web of Science ®Google Scholar
• Chiu C-C, Haung J-W, Chang F-R, Huang K-J, Huang H-M, Huang H-W, Chou C-K, Wu Y-C, Chang H-W. Golden berry-derived 4β-hydroxywithanolide E for selectively killing oral cancer cells by generating ROS, DNA damage, and apoptotic pathways. PLoS One. 2013;8(5):e64739.
   PubMed Web of Science ®Google Scholar
• Yen C-Y, Chiu C-C, Chang F-R, Chen JY-F, Hwang C-C, Hseu Y-C, Yang H-L, Lee AY-L, Tsai M-T, Guo Z-L, et al. 4beta-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest. BMC Cancer. 2010;10:46.
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee YJ. Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells. Nutr Res Pract. 2021;15(1):12–25.
   PubMed Web of Science ®Google Scholar
• Aumeeruddy MZ, Mahomoodally MF. Combating breast cancer using combination therapy with 3 phytochemicals: piperine, sulforaphane, and thymoquinone. Cancer. 2019;125(10):1600–11.
   PubMed Web of Science ®Google Scholar
• Bley K, Boorman G, Mohammad B, McKenzie D, Babbar S. A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin. Toxicol Pathol. 2012;40(6):847–73.
   PubMed Web of Science ®Google Scholar